QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

EWTX

QT55Edgewise Therapeutics, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
36.81
+1.99+5.72%
OverviewShort InterestFilings
EWTXQT55Edgewise Therapeutics, Inc.·NASDAQ
OverviewShort InterestFilings
36.81+5.72%

Latest SEC Filings

Form category
Filing Date ▾Report DateFormDescriptionFilingDocument
Jun 17, 2026Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 2026Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 2026Jun 17, 20264Statement of changes in beneficial ownership
Jun 16, 2026Jun 16, 20264Statement of changes in beneficial ownership
Jun 16, 2026Jun 16, 20264Statement of changes in beneficial ownership
Jun 16, 2026Jun 16, 20264Statement of changes in beneficial ownership
Jun 05, 2026Jun 05, 20268-KCurrent report
Jun 01, 2026Jun 01, 20268-KCurrent report
May 15, 2026May 15, 2026SC 13GBeneficial ownership statement (passive)
May 07, 2026May 07, 202610-QQuarterly report
May 07, 2026May 07, 20268-KCurrent report
May 07, 2026May 07, 2026S-8Registration of employee benefit securities
May 05, 2026May 05, 2026144Notice of proposed sale of restricted securities
May 05, 2026May 05, 20264Statement of changes in beneficial ownership
Apr 27, 2026Apr 27, 2026SC 13D/ASC 13D/A
Apr 23, 2026Apr 23, 2026DEFA14AAdditional proxy soliciting materials
Apr 23, 2026Apr 23, 2026DEF 14ADefinitive proxy statement
Apr 23, 2026Apr 23, 2026ARSARS
Apr 03, 2026Apr 03, 20264Statement of changes in beneficial ownership
Apr 02, 2026Apr 02, 20264Statement of changes in beneficial ownership
Mar 31, 2026Mar 31, 20264Statement of changes in beneficial ownership
Mar 30, 2026Mar 30, 20264Statement of changes in beneficial ownership
Mar 27, 2026Mar 27, 2026144Notice of proposed sale of restricted securities
Feb 26, 2026Feb 26, 20268-KCurrent report
Feb 26, 2026Feb 26, 202610-KAnnual report
#1 / 25 of 343
Page
▼
/ 14